GESTIFAR
Sources: the KBO register on 18-11-2026; the National Bank, 2025 annual accounts filed on 19-06-2026; the Belgian Official Gazette, latest deed of 14-07-2022.
Grounds
the facts the verdict rests on, each with its source- In 2025, GESTIFAR closed with a net profit of €55,604.Annual accounts 2025 page 2
- Equity stands at €1.7m, or 54.8% of the balance sheet total of €3.2m. That is more than 78% of the 10,644 companies in the head offices and management consultancy sector (NACE 70).Annual accounts 2025 page 2
- GESTIFAR paid out €250,000 in dividends. Because of the dividend and higher debts to suppliers, solvency fell from 61.5% to 54.8%.Annual accounts 2025 page 2
- Of the €1.4m of debt, €1.0m runs for more than a year. €76,112 of the debt is secured on the company's own assets.Annual accounts 2025, notes page 2
- The 2025 accounts reached the National Bank 42 days before the end of the term.National Bank, filing of 19-06-2026 page 5
Representation
The signing rule is in the deed of 14-07-2022.
Articles of association, Belgian Official Gazette of 14-07-2022, deed 22084995
Ownership
(0433.063.032) holds 1.36% of the shares. Its equity stood at €444,329 on 31-12-2025.
Annual accounts 2025 of
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin €m
Equity and debtsin €m
Cashin €m
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €34,820 | €92,144 | €41,032 | €121,682 | €90,246 | |
| Operating result | €11,187 | €22,532 | -€31,394 | €59,594 | €29,010 | |
| Net result | €15,960 | -€37,790 | €3,125 | €71,840 | €55,604 | |
| Balance sheet at the closing date | ||||||
| Equity | €2.1m | - | €1.9m | €1.9m | €1.7m | |
| Debts | €823,209 | €1.2m | €922,577 | €1.2m | €1.4m | |
| Debts due after more than one year | €674,288 | €1.1m | €746,743 | €1.0m | €1.0m | |
| Debts due within one year | €148,921 | €113,233 | €171,022 | €149,302 | €372,950 | |
| Cash | €158,101 | €121,514 | €5,427 | €13,255 | €22,758 | |
| Balance sheet total | €2.9m | €3.1m | €2.8m | €3.1m | €3.2m | |
| Operations | ||||||
| Employees in full-time equivalents | - | 1.2 | 1.2 | 1.1 | 1.1 | |
| Ratios | ||||||
| Solvency | 71.7% | - | 66.9% | 61.5% | 54.8% | |
| Liquidity | 11.77 | 15.05 | 8.49 | 13.37 | 5.47 | |
| From the notes | ||||||
| Debts secured on the company's own assets | €190,955 | €155,909 | €119,757 | €95,868 | €76,112 | |
Source: Annual accounts 2025, abbreviated format, filed on 19-06-2026 (2026-00180676); Annual accounts 2024, full format, filed on 23-06-2025 (2025-00168463); Annual accounts 2021 to 2023, filed from 25-07-2022 to 22-06-2024 (2022-20228778, 2023-00365315, 2024-00152180).
The operating result of 2025 is 51% lower than in 2024.
Debts rose by €225,260 in 2025, of which €1,278 to suppliers. A dividend stands among the debts on the balance sheet date until it is paid.
€76,112 of the debt is secured on the company's own assets; in 2024 it was €95,868.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
Board, signature and ownership
Position on 18-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 14-07-2022.
Articles of association, Belgian Official Gazette of 14-07-2022, deed 22084995
Board
two directors in officeOwnership and group
Shareholders
(0433.063.032) holds 1.36% of the shares. Its equity stood at €444,329 on 31-12-2025.
Annual accounts 2025 of
Board changes
Merger: GESTIFAR takes over PHARMA SERVICES. Capital increase of €17,496.02 to €48,771.02. The capital rose from €31,275 to €48,771.02. (statutory director) and (statutory director) appointed. General meeting of 17-06-2022.
Gazette, deed 22084995Registered office moved within Saint-Ghislain. The registered office moved from route de Tournai, 2-7333 Saint-Ghislain (ex-Tertre) to Rue Emile Vandervelde 3 à 7332 Saint-Ghislain (Ex-Sirault). (gérant suppléant) and (statutory manager) change roles. Legal-form conversion: from public limited company to private limited company (pre-2019). General meeting of 30-09-2015.
Gazette, deed 15152096(director) and . (director) reappointed. General meeting of 02-07-2012.
Gazette, deed 14032201reappointed as director. General meeting of 18-05-2012.
Gazette, deed 12114039Holdings
GESTIFAR has 1 direct subsidiary (own 2025 accounts).
| Country | Company | Equity | Result | |
|---|---|---|---|---|
| Belgium 1 | ||||
| BE | 98.72% | €444,329 | result €458 | |
Source: List of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.
Events and comparison
The latest events, newest first
Annual accounts 2025 filed, 42 days before the deadline.
NBB filingRegistered in the Peppol Directory. Reachable for e-invoices through 0208:0441670890.
Annual accounts 2024 filed, 38 days before the deadline.
NBB filingAnnual accounts 2023 filed, 39 days before the deadline.
NBB filingBack to profit. The net result is €3,125, after one loss-making year.
FinancialAnnual accounts 2022 filed, 28 days late.
NBB filingAnnual accounts 2021 filed, 6 days before the deadline.
NBB filingMerger: GESTIFAR takes over PHARMA SERVICES. Capital increase of €17,496.02 to €48,771.02. The capital rose from €31,275 to €48,771.02. (statutory director) and (statutory director) appointed. General meeting of 17-06-2022.
Gazette, deed 22084995Annual accounts 2020 filed, 19 days late.
NBB filingMerger proposal: GESTIFAR takes over Pharma Services. Capital increase of €30,988.52 to €62,000. The capital rose from €31,011.48 to €62,000. acts as permanent representative.
Gazette, deed 21078611Annual accounts 2019 filed, 38 days late.
NBB filingBack to profit. The net result is €251,677, after one loss-making year.
FinancialEquity above €2m. Equity rises from €1.8m to €2.1m.
FinancialAnnual accounts 2018 filed, 19 days late.
NBB filingComparable companies, two years later
In July 2024, 17,047 companies had the same profile as GESTIFAR has now: micro, 20 years or older, solvency 30% or more and a profit under 5% of the balance sheet. Two years later 94.3% were still trading, 5.2% had stopped another way and 0.5% had gone bankrupt.
In 2025, GESTIFAR had a higher net result than 55% of the 10,638 companies in the head offices and management consultancy sector (NACE 70).
Other findings
Peppol
Reachable for e-invoices since 23-12-2025, under 0208:0441670890.
Sanctions lists
Staff
2 employees on 31-12-2025, 1.1 full-time equivalents on average over the year.
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 18-11-2026 | KBO 0441.670.890 |
| National Bank of Belgium | Annual accounts 2025, abbreviated format | 19-06-2026 | 2026-00180676 |
| National Bank of Belgium | Annual accounts 2024, full format | 23-06-2025 | 2025-00168463 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 25-07-2022 to 22-06-2024 | 2022-20228778, 2023-00365315, 2024-00152180 |
| Belgian Official Gazette | Articles of association with the signing rule | 14-07-2022 | deed 22084995 |
| Belgian Official Gazette | Board | 28-10-2015 | deed 15152096 |
| Belgian Official Gazette | Board | 03-02-2014 | deed 14032201 |
| Peppol Directory | Registration for e-invoices | 23-12-2025 | 0208:0441670890 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 17-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 17-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.